Clinical Research Directory

Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Minimum age of 18 years old * Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days * Singleton pregnancy * Any indication for fetal monitoring at least twice per week (e.g.): * Pre-eclampsia (PE) * Fetal growth restriction (FGR) * Preterm pre-labor rupture of membranes (PPROM) * Absence of exclusion criteria \> 24 hours after admission. * Oral and written informed consent is obtained. Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * An indication for intravenous medication * Blood pressure \>160/110 A millimeter of mercury (mmHg) * Absent-/or reversed flow umbilical artery Doppler * Hemolysis Elevated Liver enzymes and Low Platelets (HELLP) (Table 1) * Obstetric intervention expected \<48 hours, e.g. due to: * Non reassuring cardiotocography (CTG) * Active vaginal blood loss * Signs of abruption placentae * Meconium stained amniotic fluid * Signs of chorioamnionitis * Patients admitted with a clinical diagnosis of sepsis with hypotension (i.e. septic shock). * Insufficient knowledge of Dutch or English language * Insufficient comprehension of instruction Nemo Remote® or patient information * Fetal and/or maternal cardiac arrhythmias * Contraindications to abdominal patch placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper) * Patients connected to an external or implanted electrical stimulator, such as Transcutaneous Electro Neuro Stimulation (TENS) and pacemaker (because of disturbance of the electrophysiological signal).